SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Berg Paul – ‘4’ for 4/29/03 re: Gilead Sciences Inc.

On:  Wednesday, 4/30/03, at 2:26pm ET   ·   For:  4/29/03   ·   Accession #:  1179110-3-442   ·   File #:  0-19731

Previous ‘4’:  None   ·   Next:  ‘4’ on 7/21/03 for 7/17/03   ·   Latest:  ‘4’ on 5/13/11 for 5/11/11

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/30/03  Berg Paul                         4          Director    1:9K   Gilead Sciences Inc.              Section16 Direct/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 -4/29/2003                                   HTML     11K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <! 
  Section16Direct Section 16, Form 4  
Form 4

FORM 4

[ ]Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Files pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person

Paul Berg
Beckman Center, Rm. B062
Stanford University School of Medicine
Stanford, CA 94305 US

2. Issuer Name and Ticker or Trading Symbol

Gilead Sciences, Inc. (GILD)

6. Relationship of Reporting Person(s) to Issuer

Director

________________________

 3. IRS or Social Security Number of Reporting Person (voluntary)

4. Statement for Month/Day/Year

4/29/2003

7. Individual or Joint/Group Filing

 Form filed by One Reporting Person

5. If Amendment, Date of Original (Month/Day/Yr)

Original Date

N/A
 

Table I-Non-Derivative Securities Acquired,Disposed of, or Beneficially Owned

1. Title of Security2. Transaction Date
(Month/Day/Year)
2A. Deemed
Execution Date
if any
(Month/Day/Year)
3. Transaction
Code
4. Securities Acquired (A)
or Disposed of (D)
5. Amount of Securities
Beneficially Owned
Following Reported
Transaction(s)
6. Ownership Form:
Direct (D) or
Indirect (I)
7. Nature of Indirect
Beneficial
Ownership
Code
V
Amount
(A) or (D)
Price
Table II-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Derivative Security2. Conversion
or Exercise
Price of
Derivative
Security
3. Transaction
Date
(Month/Day/Year)
3A. Deemed
Execution Date
if any
(Month/Day/Year)
4. Transaction Code5. Number of Derivative
Securities Acquired
(A) or Disposed of (D)
6. Date Exercisable
and Ex-piration Date
(Month/Day/Year)
7. Title and Amount of
Underlying Securities
8. Price of
Derivative
Security
9. Number of
Derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
10. Ownership
Form of
Derivative
Security:
Direct(D)or
Indirect (I)
11. Nature
of Indirect
Beneficial
Ownership
Code
V
(A)
(D)
Date
Exercisable
Expiration
Date
TitleAmount or
Number of
Shares
Non-Qualified Stock Option (right to buy)
46.3600
4/29/2003
A
21,000
4/29/2004
4/29/2113
Common Stock
21,000
21,000
D
Explanation of Responses
(1) Granted pursuant to the Gilead Sciences, Inc. 1995 Directors' Stock Option Plan in a transaction exempt from Rule 16b-3. (2) Options vest 100% on first anniversary date of the grant.

**Intentional misstatements or omissions of facts constiute Federal Criminal Violations.
See 18 U.S.C. 1001 and 15U.S.C. 78ff(a).

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

 

Signature of Reporting Person: /s/ Paul Berg

Date: 4/29/2003
   

 

 

Top
Filing Submission 0001179110-03-000442   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 8:32:40.1pm ET